Hangzhou Biotest Biotech Co Ltd (688767) — Free Cash Flow Generation Index
Hangzhou Biotest Biotech Co Ltd (688767) has a Free Cash Flow Generation Index of -0.66x as of September 2025. Free cash flow of CN¥-18.63 Million represents -1% of operating cash flow (CN¥28.39 Million). See Hangzhou Biotest Biotech Co Ltd (688767) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hangzhou Biotest Biotech Co Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Explore 688767 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Hangzhou Biotest Biotech Co Ltd. For the full company profile including market capitalisation, see Hangzhou Biotest Biotech Co Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.22x | CN¥-23.40 Million | CN¥106.47 Million | CN¥129.87 Million | ▲ +75.6% |
| 2024 | -0.90x | CN¥-116.23 Million | CN¥128.83 Million | CN¥245.05 Million | ▼ -258.1% |
| 2023 | 0.57x | CN¥74.96 Million | CN¥131.38 Million | CN¥56.42 Million | ▼ -23.5% |
| 2022 | 0.75x | CN¥524.29 Million | CN¥703.21 Million | CN¥178.92 Million | ▼ -4.4% |
| 2021 | 0.78x | CN¥707.92 Million | CN¥908.12 Million | CN¥200.20 Million | ▼ -10.5% |
| 2020 | 0.87x | CN¥388.38 Million | CN¥446.07 Million | CN¥57.68 Million | ▲ +261.9% |
| 2019 | -0.54x | CN¥-13.81 Million | CN¥25.67 Million | CN¥39.47 Million | ▼ -233.9% |
| 2018 | 0.40x | CN¥8.50 Million | CN¥21.17 Million | CN¥12.67 Million | ▲ +114.7% |
| 2017 | -2.73x | CN¥-19.30 Million | CN¥7.07 Million | CN¥26.37 Million | — |